The Scientist

» FDA and developmental biology

Most Recent

image: Trump Announces HHS, CMS Picks

Trump Announces HHS, CMS Picks

By | November 30, 2016

President-elect Donald Trump chooses Representative Tom Price to lead the Department of Health and Human Services, Seema Verma to lead the Centers for Medicare and Medicaid Services.

1 Comment

image: Live Imaging Using Light-Sheet Microscopy

Live Imaging Using Light-Sheet Microscopy

By | November 1, 2016

How to make the most of this rapidly developing technique and a look at what's on the horizon

0 Comments

image: Opinion: Aging, Just Another Disease

Opinion: Aging, Just Another Disease

By | November 1, 2016

No longer considered an inevitability, growing older should be and is being treated like a chronic condition. 

26 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

image: Bridging a Gap in the Brain

Bridging a Gap in the Brain

By | October 12, 2016

Neuroscientists identify how the left and right hemispheres of the mammalian brain connect during development.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Conditional FDA Approval for Fatal-Disease Drug

Conditional FDA Approval for Fatal-Disease Drug

By | September 19, 2016

The agency OKs Sarepta Therapeutics’s treatment for Duchenne muscular dystrophy through its accelerated approval pathway, which requires a confirmatory clinical trial.

0 Comments

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham